New Real-World Evidence Shows Improvements in Outcomes and Reduction in Healthcare Costs with Guidance® UTI Precision Diagnostic Test Compared to Standard Urine Culture in Patients with Complicated Urinary Tract Infections
The Californer/10191870

Medicare database analysis presented at the 2022 American Urology Association Meeting found 44% lower total costs and 77% lower clinically-advanced costs with Guidance UTI versus standard urine culture (SUC)

IRVINE, Calif., May 14, 2022 /PRNewswire/ -- Real-world evidence from a Medicare database analysis presented today at the 2022 American Urology Association (AUA) Meeting shows that Guidance UTI testing is associated with reductions in critical adverse outcomes, healthcare resource utilization and costs for complicated urinary tract infections (cUTIs) compared to standard urine culture (SUC). The comparative analysis was designed to examine outcomes of one year of cUTI treatment guided by either Guidance UTI or SUC.

More on The Californer

• Long Beach Parks, Recreation and Marine to Offer Winter Recreation Classes
• Active Skin Repair: The Clean, Medical-Grade Solution Transforming Skin Health
• Long Beach: City to Host Planning for Housing Open House and Community HOME Roadshow
• Zachary Hunchar Unleashes His Debut Horror Novel — The Grange
• Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"

---

Show All News | Report Violation